Coronavirus Outbreak: Small business credit worth Rs 2.32 lakh cr at highest risk of default, warns CIBIL

Small business credit of Rs 2.32 lakh crore is at the highest risk of default, and micro enterprises having loan outstanding of less than Rs 10 lakh are the most vulnerable because of the COVID-19 pandemic, a credit information company said on Wednesday

Press Trust of India April 22, 2020 13:28:04 IST
Coronavirus Outbreak: Small business credit worth Rs 2.32 lakh cr at highest risk of default, warns CIBIL

Mumbai: Small business credit of Rs 2.32 lakh crore is at the highest risk of default, and micro enterprises having loan outstanding of less than Rs 10 lakh are the most vulnerable because of the COVID-19 pandemic, a credit information company said on Wednesday.

It can be noted that ever since the outbreak of the virus infections and the subsequent lockdown that is scheduled to last at least 40 days, concerns are being raised about the financial health of small businesses.

Click here to follow LIVE updates on coronavirus outbreak

In its study, TransUnion CIBIL said, at present, the total outstanding amount of all financiers to small businesses having a credit outstanding of less than Rs 50 crore is Rs 17.94 lakh crore, representing 28 percent of the total outstanding credit.

Coronavirus Outbreak Small business credit worth Rs 232 lakh cr at highest risk of default warns CIBIL

Representational image. Reuters

The bureau has launched an enhanced methodology to include enterprises having less than Rs 10 lakh outstanding as well to assess their health.

“The ongoing COVID-19 pandemic poses new challenges to businesses, especially for micro enterprises, who are often more vulnerable to sudden changes in the economic environment,” its managing director and chief executive Rajesh Kumar said.

Click here to follow LIVE news and updates on stock markets

The agency said the number of micro, small and medium enterprises (MSMEs) falling in the highest risk bracket of “CMR-7 to CMR-10” have outstanding credit balances of Rs 2.32 lakh crore, which is at a higher risk of slipping into becoming a non-performing asset (NPA).

Out of this, the credit to enterprises with less than Rs 10 lakh outstanding alone totals up to Rs 13,600 crore in the overall credit bracketed as the most risky, it said, adding that their overall loan balance is Rs 93,000 crore.

The overall NPA ratio for small businesses has been growing over the past few years and stood at 12.6 percent as at December 2019, the bureau said, adding the CMR is a credit risk rank that predicts the probability of a small business loan turning bad in 12 months.

It can be noted that the Reserve Bank has permitted a three-month moratorium on all term loan repayments between March-May.

The bureau said with the enhanced offering, its coverage of companies having less than Rs 50 crore in borrowings can go up to 90 lakh entities including the 55 lakh ones of under Rs 10 lakh borrowings.

State-run Small Industries Development Bank of India's chairman and managing director Mohammad Mustafa said the enhanced offering comes at a “very crucial time” and hoped for it to help fuel the economy by providing smaller businesses access to credit.

Updated Date:

also read

Dengue cases climb in West Bengal, 840 new infections in run-up to festival
India

Dengue cases climb in West Bengal, 840 new infections in run-up to festival

Most of the cases have been reported from North 24 Parganas, Howrah, Kolkata, Hooghly, Murshidabad, South 24 Parganas, Jalpaiguri and Darjeeling districts

COVID-19: Active Covid cases in India rise to 46,342
Health

COVID-19: Active Covid cases in India rise to 46,342

The active cases comprise 0.10 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.71 per cent.

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns
World

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns

China hasn’t approved any foreign vaccine and has been insisting on sharing the technology behind the Moderna vaccine as a prerequisite for allowing its sale in the country